https://www.mskcc.org/cancer-care/clinical-trials/25-167
Full Title A Phase 3, Multicenter, Double-Blind, Placebo-controlled Study Assessing the Efficacy and Safety of Olomorasib in Combination with Standard of Care...
phasestudyolomorasibplusimmunotherapy